I write to acknowledge the support of the Emily Taylor Travel Grant to facilitate me to travel to Lisbon to attend EHRA Congress. As a Cardiac Electrophysiology and Device trainee it was extremely important for me to attend this congress. I had the opportunity to attend important scientific sessions which helped me to further shape my career in Electrophysiology and Devices. I have attended several hands-on sessions particularly in arrhythmia mapping and ablations. There were few sessions mainly for trainees which I found extremely useful. This congress also gave me an opportunity to interact with experts and fellow trainees from around the world. On return I shared the latest evidences in the field from the congress with fellow trainees and my supervisors.
I am extremely grateful to the Scottish Cardiac Society for the kind support I received.
I write to acknowledge the support of the Emily Taylor Travel Grant which facilitated my attendance at the American Heart Association Conference in Chicago, 2018. We were invited to present our publication into the use of clinical risk scores in patients with suspected acute coronary syndrome at the annual Circulation highlights session. This was a unique opportunity to meet and present to the editors of Circulation, and to have discussion with leading experts in the field. During the AHA meeting, I was also present at a roundtable discussion with experts who lead the task force for the Fourth Universal Definition of Myocardial Infarction. In the coming months we will publish an updated consensus review hoping to aid clinicians in the diagnosis of myocardial injury and infarction. Without the support of the Emily Taylor Grant I would not have been able to attend either meeting, and I am very grateful for the ongoing support of the Scottish Cardiac Society.
Dr Andrew Chapman
Specialist Registrar in Cardiology
I am extremely grateful to the SCS for supporting my travel to the British Society of Echocardiography Annual Meeting in Liverpool on 5th to 6th October 2018. The conference programme was extremely educational, and this has been invaluable to help me in my transthoracic echocardiography reaccreditation. Due to limited funds being available from NHS Education for Scotland, the financial help from the SCS was key in enabling my attendance.
I am extremely grateful to the Scottish Cardiac Society and the Emily Taylor Travel Grant for the financial assistance given in relation to my abroad Fellowship in Electrophysiology at St Vincent’s Hospital, Sydney. St. Vincent’s Hospital is a busy quaternary heart and lung transplant hospital in the central Sydney. During my 9 month fellowship programme in Sydney, I took part in over 600 procedural cases including diagnostic EP studies, ablation for atrial fibrillation, SVT, atrial flutter and ventricular tachycardia. Devices cases include single and dual chamber pacemakers, ICD (including subcutaneous ICDs), CRT and implantable loop recorders. Furthermore, I provided the clinical EP input for the public hospital.
This fellowship enhanced my skills and knowledge base and offered an intensive teaching and training opportunity, allowing me to complete cardiac rhythm training to the highest possible standard prior to returning to Scotland and beginning my consultant career.
This time working abroad allowed me to experience the positive aspects that an international fellowship programme brings, not only furthering my medical training but broadening my horizons and experiencing new cultures and healthcare systems. I would recommend a period of time working abroad to all trainees. It was my first experience working abroad, and outwith the NHS, and it allowed me to reflect upon how fortunate we are to have a healthcare system like the NHS.
Once again, I am extremely grateful to the Scottish Cardiac Society for the assistance given.
I am writing to express my gratitude for supporting my travel to this international conference. I am a sub-specialty trainee in coronary intervention. My submission to Euro-PCR 2018 conference was accepted for oral presentation. While I was pleased to present at this prestigious meeting, I was slightly concerned about the travel and accommodation costs to Paris, as the registration fee alone was eight hundred pounds. I heard from my colleague on the Scottish Cardiac Society – Emily Taylor travel fund and decided to apply for it. The application process, communication from SCS and the whole process was very easy and smooth. I was pleasantly surprised that my application was granted.
The Euro-PCR 2018 was attended by 12,000 experts from around the globe. There were new trial report presentations, novel coronary and peripheral intervention techniques and lectures on management of complications during percutaneous intervention. The study gave excellent chance to meet experts from Europe and around the globe, especially as I am applying for an interventional fellowship.
My presentation on a complex coronary intervention performed by Dr Deepak Garg and myself at Aberdeen Royal Infirmary, was well received by the moderators and the audience. They lauded our interventional technique. It was great to know that what we did in some corner of Scotland was of international standard, and more! I have urged my junior fellows to submit more cases and outcomes from our centre in future meetings. The whole experience from the conference was exceptional and I cannot thank Scottish Cardiac Society and our local girl-Emily Taylor for this generous sponsorship.
I have been very fortunate to have been granted funds from the Emily Taylor Travel Grant this May, enabling me to attend a large international conference in Boston; Heart Rhythm Society 2018. The conference attracts EP specialists worldwide, and with over 12,000 delegates, provided an amazing platform to present our analysis on outcomes in RV pacing within NHS Lothian.
In brief, we undertook a large retrospective analysis of long-term clinical outcomes following pacemaker insertion, stratified according to RV lead insertion site. The analysis provides valuable data to the literature, where there is still lack of consensus. The sessions were extremely well attended and there was a great deal of interactive and engaged discussion around my presented work, and it was both interesting and useful to gain feedback and thoughts of others from different centres, on this common clinical question. There is no doubt that it has informed my write-up and improved the quality of the manuscript immeasurably.
The conference also provided an excellent opportunity to meet and re-kindly relationships with EP professionals from other departments in which I have worked. Opportunities to see these people are infrequent but important in maintaining links between our institutions.
I am extremely grateful to have been granted funds for the second time within my PhD. It has enabled attendance at highly educational meetings which would have been otherwise impossible.
I am very grateful to the Scottish Cardiac Society for the Emily Taylor Travel Award. This enabled me to attend the 2018 Royal College of Nursing and Midwifery International Nursing Research Conference in Birmingham, where I presented my poster on patient recruitment into research within an acute cardiology setting. The conference was attended by research nurses and nurse researchers from a range of different specialties and institutions. Despite being from different specialties, many people had experienced similar challenges when recruiting patients to clinical trials. My poster stimulated some great discussion with other research teams around different recruitment strategies and I received many valuable comments. I was able to take back some of these suggestions to the team, which may be beneficial for our future research studies.
It was a very informative conference with many networking opportunities. I was able to hear about nursing research developments and speak to many experienced researchers about the different methodologies they had used. This will be beneficial to me in my future career as I hope to undertake my own cardiology research project. Furthermore, it was highly valuable speaking to research teams who have undertaken patient and public involvement work, as our team were in the process of developing a patient advisory group. Since this conference we have had our first patient and public involvement meeting with our patient advisory panel, which was a great success.
I am extremely grateful to the Scottish Cardiac Society for agreeing to support my travel to the Philips Cardiac CT course in London, from the 6th to the 10th of February 2018. This was an intensive, non profit, course which covered all aspects of cardiac CT. This included lectures, reporting cases and watching live CT acquisition. The Faculty were all level 3 accredited, highly experienced CT consultants and the technical support from Philips was exceptional. This course allowed me to gain level 2 accreditation in cardiac CT; this would have taken several months to do without a course. It was also extremely useful as cardiac CT is not available in my local hospital so I would have had to travel to other NHS trusts to gain day to day training.
I would like to thank the society again for supporting me. Without their support I would not have been able to attend this course.
Dr Fiona Shearer
I am very grateful to the Scottish Cardiac Society for supporting my travel to the EHRA EUOPACE-CARDIOSTIM 2017 congress held in Vienna between the 18th and 21st June 2017. As a final year trainee in cardiac devices, this was an excellent forum highlighting the latest and the best in the field of implantable cardiac devices.
I attended some excellent sessions by world-renowned speakers in the field of cardiac devices. Of particular interest to me were sessions on alternative site ventricular pacing – an area of that bears great potential and is definitely creating a lot of interest amongst electrophysiologists and device experts around the globe. The congress also had very interesting sessions on real world experience on the latest technology in the field of devices – such as subcutaneous ICDs and the leadless pacemaker technology. It was also very educational to watch experts describe their ‘nightmare cases’ of cardiac resynchronisation therapy implants in the cath lab and how they tackled them. Live demo sessions were a great resource to observe and learn new techniques/ equipment available that would be of great value in difficult CRT implants. In addition to all of this, the congress provided a great platform for networking with peers and colleagues.
This travel fund also allowed me to take the extremely challenging EHRA (European Heart Rhythm Association) accreditation exam in cardiac devices that was held on the first day of the congress meeting. I am very pleased to inform the Society that I have successfully passed this exam providing me with Level 1 accreditation in cardiac devices. Finally, I thoroughly enjoyed Vienna and it’s awesome weather!
I thank the Society for their on-going support and hope that I can translate the knowledge gained at this conference into clinical practice.
I am profoundly grateful to Scottish Cardiac Society to support me to attend and present at EuroPCR 2017.
EuroPCR is the official annual meeting of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) and the world-leading Course in Interventional Cardiovascular Medicine.
Nearly 11,800 interventional cardiologists, nurses, technicians, scientists and industry innovators from around the world shared the latest developments, research, and best practice in treating cardiovascular conditions, including coronary and valvular heart disease and stroke, with minimally invasive endovascular techniques.
EuroPCR celebrated 40 years of angioplasty this year with an exhibition tracing the major milestones in the pioneering history of interventional cardiology. The first EAPCI fellows course was held in conjunction with EuroPCR with interactive lectures from leaders in the field. Stent-Save a life programme was launched during this conference, which involved meeting of representatives from more than 60 countries to discuss the improvement in access to latest therapies and reduction in mortality and morbidity in patients with STEMI.
I was able to preset my case report during a session on technical aspects of complex left main PCI. The session was well attended by the consultants and registrars from all over the world. I had also been able to attend many simulator sessions to gain new skills in interventional cardiology.
I was able to share my experience with colleagues from all across the world and the live sessions during the conference were a great resource to observe international practice in interventional cardiology and interact with the panel of interventionists and attendees. The sessions on complications during PCI were very useful to learn about management of complicated cases.
The Emily Taylor grant helped me to attend the conference, share knowledge and experience with professionals from around the world and learn new skills in interventional cardiology. I am hopeful that my knowledge and skills will be used for improvement of many lives of patients with cardiac problems in general and ischemic heart disease in particular.
Dr Agha Haider Imran